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ABSTRACT
Mitotic arrest can result in cell death through the process of apoptosis. We have shown by live-cell
imaging that the ubiquitin-proteasome dependent proteolysis of the apoptotic regulator Mcl-1 under
the control of the anaphase-promoting complex or cyclosome (APC/C) provides a timing mechanism
that distinguishes prolonged mitotic arrest from normal mitosis.
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Induction of the intrinsic pathway of apoptosis in cells arrested in
mitosis results in mitotic cell death. This process is thought to
remove cells that have failed mitosis and thereby protects an
organism against the propagation of chromosomal defects.
Mitotic cell death can be induced pharmacologically (at least in
vitro) by microtubule poisons such as paclitaxel that arrest cells in
mitosis through prolonged activation of the mitotic or spindle
assembly checkpoint. Cells arrested in mitosis appear to be parti-
cularly sensitive to BH3 (Bcl-2 homology domain 3) mimetic
drugs that target anti-apoptotic proteins of the Bcl-2 family,
namely Bcl-2 (BCL2), Bcl-xL (BCL2L1) and Mcl-1 (MCL1).
1–3
Phosphorylation of Bcl-2, Bcl-xL and the apoptosis inhibitor
XIAP (X-linked inhibitor of apoptosis) is thought to reduce their
protective activity during mitosis, but these modifications do not
appear to change during mitotic arrest,4–6 suggesting that another
mechanism is responsible for the initiation of mitotic cell death.
Mcl-1 is a particularly interesting player in the control of
responses to the disruption of mitosis. Mcl-1 is an unstable, cell
cycle-regulated protein that accumulates during interphase and
reaches a peak around late G2 phase (ref 4; see Figure 1). In
mitosis, the level of Mcl-1 protein declines, and this loss has
been proposed to promote apoptosis in cells held in mitotic
arrest.1–5,7 Indeed, ablation of Mcl-1 promotes mitotic cell
death while enhanced expression of the protein inhibits this
process.2,3 Phosphorylation of Mcl-1 at Thr92 by the mitotic
protein kinase CDK1-cyclin B promotes degradation of the
protein,4,7 indicating a link between entry into mitosis and
destabilisation of the protein, but the mechanism that controls
Mcl-1 destruction during mitotic arrest has been controversial.
A key component in the mitotic destruction of Mcl-1 is the
ubiquitin E3 ligase that catalyses the poly-ubiquitylation of Mcl-1
and primes it for recognition by the proteasome. Biochemical
analyses of the pathways leading tomitotic cell death are restricted
by the limited ability to follow the temporal regulation of the
process and admixture of early G1 cells due to mitotic slippage.
To counter these limitations, we recently employed a live-cell
imaging approach pioneered in the analysis of mitotic protein
destruction by Pines and others (e.g. Ref 8) in which the protein
of interest is expressed as a fusion with a fluorescent protein
derived from Aequorea and its degradation is monitored min-
ute-by-minute during mitosis in individual cells. Caveats to this
approach are that the fusion protein might be altered in its mole-
cular interactions, regulation or localisation compared to the
endogenous protein. We used an N-terminal Yellow Fluorescent
Protein fusionwithMcl-1 (YFP-Mcl-1)which, although expressed
at a higher level than the endogenous protein, was phosphorylated
and degraded with similar kinetics to the endogenous protein
during mitotic arrest, and was functional in inhibiting apoptosis.9
We demonstrated that YFP-Mcl-1 loss during mitotic arrest
occurs relatively slowly compared to cyclin A, but is faster than
the checkpoint-inhibited degradation of cyclin B. We confirmed
our previous biochemical data (ref 4) that Mcl-1 degradation
during mitotic arrest is dependent on the catalytic subunits of
the ubiquitin E3 ligase APC/C (anaphase-promoting complex or
cyclosome) and showed that it is not dependent on FBW7
(encoded by the FBXW7 gene, also known as hCDC4), a substrate
recognition component of the SCF complex that regulates Mcl-1
stability in response to its phosphorylation by GSK3.7,10
Bymutation of YFP-Mcl-1, we identified a D boxmotif similar
to that found in other APC/C substrates that is required for
efficient degradation during mitotic arrest. Revealingly, deletion
of a C-terminal motif consisting of Isoleucine-Arginine (IR)
changes the APC/C subunit requirements for Mcl-1 degradation
and changes it from an atypical APC/C substrate that is not
stimulated by the APC/C cofactor CDC20 (or the related cofactor
CDH1) to one that is rapidly degraded in a conventional CDC20-
dependent manner once the checkpoint is switched off, similar to
cyclin B. We propose that the IR tail ensures that Mcl-1 is ubiqui-
tylated slowly by basal APC/C activity, such that its rate of loss is
not affected by the strength of the checkpoint and it is not
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catastrophically destroyed when the checkpoint is switched off.
The level of Mcl-1 is reduced below the threshold to permit
apoptosis only after a cell has become stuck in mitosis for a
prolonged period andnot during normalmitosis. Thismechanism
provides an opportunity to promotemitotic cell death by arresting
cells inmitosis with a reagent like TAME (tosyl-L-argininemethyl
ester) that inhibits CDC20-dependent APC/C activity towards
cyclin B and while permitting Mcl-1 destruction. Our study raises
a number of questions about the mechanism ofMcl-1 recognition
and ubiquitination by theAPC/C that will probably require recon-
stitution of the reaction in vitro for resolution.
Our work has shown that the steady rate of Mcl-1 destruction
during mitosis provides an apoptotic timer that is independent of
checkpoint strength. At the end of mitosis, Mcl-1 degradation is
presumably stoppedwhenCDK1-cyclin B activity is reduced,Mcl-
1 becomes dephosphorylated at Thr92 and the APC/C is switched
off. If spindle assembly cannot be completed successfully, however,
then loss of Mcl-1 below the threshold required to restrain apop-
tosis may initiate cell death during mitosis (see Figure 1).
Interestingly, reduction ofMcl-1 also appears to permit sub-apop-
totic caspase activation in cells that do not undergo apoptosis,
leading to an interphase stress response that determines subse-
quent cell fate.2 We speculate that this sustained response to the
disruption of mitosis under the control of Mcl-1 may be as
important as mitotic cell death for the clinical effects of micro-
tubule poisons and BH3 mimetic drugs on tumours.
Abbreviations
APC/C anaphase-promoting complex or cyclosome.
BH3 Bcl-2 homology domain 3
CDK1 cyclin-dependent kinase 1
D box Destruction box
FBW7 F-Box and WD repeat domain containing protein 7
GSK3 glycogen synthase kinase 3
IR Isoleucine-Arginine.
Mcl-1 Myeloid Cell Leukemia 1
SCF SKP1-cullin-1-F-box complex
XIAP X-linked inhibitor of apoptosis
YFP Yellow Fluorescent Protein
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Figure 1. Cell cycle–dependent regulation of Mcl-1 levels and mitotic cell death.
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Mcl-1 levels drop below a critical level during a prolonged mitotic arrest caused by unresolved spindle assembly, for instance due to disruption of microtubules by a
drug, resulting in mitotic cell death by the intrinsic apoptotic pathway.
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